Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23190520)

1.

High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.

Pruijm M, Schmidtko J, Aho A, Pagano S, Roux-Lombard P, Teta D, Burnier M, Vuilleumier N.

Ther Apher Dial. 2012 Dec;16(6):588-94. doi: 10.1111/j.1744-9987.2012.01102.x. Epub 2012 Sep 12.

PMID:
23190520
2.

Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.

Pagano S, Satta N, Werling D, Offord V, de Moerloose P, Charbonney E, Hochstrasser D, Roux-Lombard P, Vuilleumier N.

J Intern Med. 2012 Oct;272(4):344-57. doi: 10.1111/j.1365-2796.2012.02530.x. Epub 2012 Mar 26.

PMID:
22329401
3.

Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis.

Wick PA, Mombelli A, Pagano S, Moren X, Giannopoulou C, Mach F, Roux-Lombard P, Vuilleumier N.

J Periodontal Res. 2013 Jun;48(3):350-6. doi: 10.1111/jre.12014. Epub 2012 Oct 11.

PMID:
23050768
4.

Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability.

Montecucco F, Vuilleumier N, Pagano S, Lenglet S, Bertolotto M, Braunersreuther V, Pelli G, Kovari E, Pane B, Spinella G, Pende A, Palombo D, Dallegri F, Mach F, Roux-Lombard P.

Eur Heart J. 2011 Feb;32(4):412-21. doi: 10.1093/eurheartj/ehq521. Epub 2011 Jan 11.

5.

Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.

Vuilleumier N, Bas S, Pagano S, Montecucco F, Guerne PA, Finckh A, Lovis C, Mach F, Hochstrasser D, Roux-Lombard P, Gabay C.

Arthritis Rheum. 2010 Sep;62(9):2640-50. doi: 10.1002/art.27546.

6.

Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.

Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P.

Clin Sci (Lond). 2008 Jul;115(1):25-33.

7.

Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.

Vuilleumier N, Rossier MF, Pagano S, Python M, Charbonney E, Nkoulou R, James R, Reber G, Mach F, Roux-Lombard P.

Eur Heart J. 2010 Apr;31(7):815-23. doi: 10.1093/eurheartj/ehq055. Epub 2010 Feb 22.

8.

Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients.

Ashikaga E, Honda H, Suzuki H, Hosaka N, Hirai Y, Sanada D, Nakamura M, Nagai H, Matsumoto K, Kato N, Mukai M, Watanabe M, Takahashi K, Shishido K, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):315-22. doi: 10.1111/j.1744-9987.2009.00796.x.

PMID:
20609185
9.

Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.

Bossola M, Tazza L, Merki E, Giungi S, Luciani G, Miller ER, Lin EB, Tortorelli A, Tsimikas S.

Blood Purif. 2007;25(5-6):457-65. Epub 2007 Dec 13.

PMID:
18075247
10.

Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress.

Pupim LB, Himmelfarb J, McMonagle E, Shyr Y, Ikizler TA.

Kidney Int. 2004 Jun;65(6):2371-9.

PMID:
15149350
11.

Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy.

Vuilleumier N, Montecucco F, Spinella G, Pagano S, Bertolotto M, Pane B, Pende A, Galan K, Roux-Lombard P, Combescure C, Dallegri F, Mach F, Palombo D.

Thromb Haemost. 2013 Apr;109(4):706-15. doi: 10.1160/TH12-10-0714. Epub 2013 Jan 31.

PMID:
23364307
12.

Definition of human apolipoprotein A-I epitopes recognized by autoantibodies present in patients with cardiovascular diseases.

Teixeira PC, Ducret A, Ferber P, Gaertner H, Hartley O, Pagano S, Butterfield M, Langen H, Vuilleumier N, Cutler P.

J Biol Chem. 2014 Oct 10;289(41):28249-59. doi: 10.1074/jbc.M114.589002. Epub 2014 Aug 28.

13.

High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.

Santos AO, Fonseca FA, Fischer SM, Monteiro CM, Brandão SA, Póvoa RM, Bombig MT, Carvalho AC, Monteiro AM, Ramos E, Gidlund M, Figueiredo Neto AM, Izar MC.

Clin Chim Acta. 2009 Aug;406(1-2):113-8. doi: 10.1016/j.cca.2009.06.005. Epub 2009 Jun 10.

PMID:
19523463
14.

Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.

O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A.

Arthritis Rheum. 2010 Mar;62(3):845-54. doi: 10.1002/art.27286.

15.

Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.

Lobo J, Santos F, Grosso D, Lima R, Barreira AL, Leite M Jr, Mafra D, Abdalla DS.

Nephron Clin Pract. 2008;108(4):c298-304. doi: 10.1159/000127982. Epub 2008 Apr 24.

PMID:
18434752
16.

Low levels of vitamin C in dialysis patients is associated with decreased prealbumin and increased C-reactive protein.

Zhang K, Liu L, Cheng X, Dong J, Geng Q, Zuo L.

BMC Nephrol. 2011 May 6;12:18. doi: 10.1186/1471-2369-12-18.

17.

Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.

Perunicic-Pekovic G, Pljesa S, Rasic-Milutinovic Z, Stankovic S, Ilic M, Maletic R.

Can J Physiol Pharmacol. 2008 Apr;86(4):205-9. doi: 10.1139/Y08-018.

PMID:
18418430
18.

Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients.

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Fermo I, Focà A, Paroni R, Malatino LS.

J Hypertens. 2000 Sep;18(9):1207-13.

PMID:
10994751
19.

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T.

Kidney Int. 1999 May;55(5):1899-911.

20.

Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives.

Teixeira PC, Cutler P, Vuilleumier N.

Clin Dev Immunol. 2012;2012:868251. doi: 10.1155/2012/868251. Epub 2012 Nov 20. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk